Age-related Cognitive Decline: Clinical Trials

2 trials for Age-related Cognitive Decline, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 1, Unknown 1

Follow Age-related Cognitive Decline: new trials by email Literature Review of Age-related Cognitive Decline trials Research Report on Age-related Cognitive Decline

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
OsteoPreP: Food Supplements for Postmenopausal Bone Health
Pendulum WBF-038, Pendulum Placebo - Postmenopausal Osteopenia, Bone Loss, Age Related
Phase 4UnknownAustralian Catholic University1602022-05-012024-07-09
Remediation of Age-related Cognitive Decline: Vortioxetine and Cognitive Training
Vortioxetine 10 mg, Cognitive training program - Age-related Cognitive Decline
Phase 4CompletedWashington University School of Medicine1292016-08-312020-01-14

Narrower conditions

Glucose Metabolism Disorders (1)  ·  Osteoporosis (1)  ·  Osteoporosis, Postmenopausal (1)

Broader conditions

Bone Diseases (1)  ·  Bone Diseases, Metabolic (1)  ·  Metabolic Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

Vortioxetine (1)

Sponsors

Australian Catholic University (1)  ·  Washington University School of Medicine (1)

Countries

Australia (1)  ·  United States (1)

Top investigators

Eric Lenze, MD (1)  ·  John Hawley, PhD (1)

Results publications

PMID 32212856, PMID 39683612